Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non-muscle-invasive Bladder Cancer. - Linehan J; Agarwal PK; Penny X; Kates M; Jacob J; Lerner SP; Kines RC; Schiller JT; de Los Pinos E; Shore ND; Hopkins J; McQuaid J; et al. (European urology open science, 2026)